Profound Medical 

$7.44
12
+$0.07+0.95% Tuesday 20:00
+$0.00+0%Tuesday 20:00After hours

Statistics

Day High
7.45
Day Low
7.44
52W High
8.95
52W Low
3.76
Volume
2,102
Avg. Volume
-
Mkt Cap
270.35M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.72
-0.57
-0.41
-0.26
Expected EPS
-0.344546425
Actual EPS
N/A

Financials

-264.44%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
16.1MRevenue
-42.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PROF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
EDAP TMS.
EDAP
Mkt Cap161.92M
EDAP TMS SA specializes in therapeutic ultrasound and HIFU technologies, directly competing with Profound Medical's TULSA-PRO system.
Intuitive Surgical
ISRG
Mkt Cap150.88B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, overlapping with Profound Medical's minimally invasive approaches.
Medtronic
MDT
Mkt Cap106.49B
Medtronic plc manufactures and sells device-based medical therapies, including those for prostate health, competing in similar therapeutic areas.
Boston Scientific
BSX
Mkt Cap67.09B
Boston Scientific Corporation develops minimally invasive medical devices, competing in the interventional medicine space.
Globus Medical
GMED
Mkt Cap10.88B
Globus Medical, Inc. focuses on musculoskeletal solutions but also explores technologies that could compete in minimally invasive treatments.
Stryker
SYK
Mkt Cap125.18B
Stryker Corporation specializes in medical technologies across various fields, including surgical devices that could compete with Profound's offerings.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but is expanding into new technologies that could compete with minimally invasive treatments.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson engages in the development of medical devices, including surgical systems that could rival Profound Medical's technologies.
Abbott Laboratories
ABT
Mkt Cap166.17B
Abbott Laboratories offers a broad range of medical devices, potentially competing in the same healthcare segments as Profound Medical.

About

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Show more...
CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
Employees
142
Country
Canada
ISIN
CA74319B5027

Listings

0 Comments

Share your thoughts

FAQ

What is Profound Medical stock price today?
The current price of PROF is $7.44 USD — it has increased by +0.95% in the past 24 hours. Watch Profound Medical stock price performance more closely on the chart.
What is Profound Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Profound Medical stocks are traded under the ticker PROF.
Is Profound Medical stock price growing?
PROF stock has risen by +10.22% compared to the previous week, the month change is a +13.24% rise, over the last year Profound Medical has showed a +24.1% increase.
What is Profound Medical market cap?
Today Profound Medical has the market capitalization of 270.35M
When is the next Profound Medical earnings date?
Profound Medical is going to release the next earnings report on July 30, 2026.
What were Profound Medical earnings last quarter?
PROF earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.25 USD resulting in a +24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Profound Medical revenue for the last year?
Profound Medical revenue for the last year amounts to 16.1M USD.
What is Profound Medical net income for the last year?
PROF net income for the last year is -42.57M USD.
How many employees does Profound Medical have?
As of July 08, 2026, the company has 142 employees.
In which sector is Profound Medical located?
Profound Medical operates in the Health & Wellness sector.
When did Profound Medical complete a stock split?
The last stock split for Profound Medical was on October 16, 2019 with a ratio of 1:10.
Where is Profound Medical headquartered?
Profound Medical is headquartered in Mississauga, Canada.